Does RIFAMPIN Cause Myelosuppression? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Myelosuppression have been filed in association with RIFAMPIN (Rifampin). This represents 0.1% of all adverse event reports for RIFAMPIN.
13
Reports of Myelosuppression with RIFAMPIN
0.1%
of all RIFAMPIN reports
2
Deaths
2
Hospitalizations
How Dangerous Is Myelosuppression From RIFAMPIN?
Of the 13 reports, 2 (15.4%) resulted in death, 2 (15.4%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAMPIN Cause?
Drug ineffective (1,238)
Drug reaction with eosinophilia and systemic symptoms (1,049)
Drug interaction (735)
Pyrexia (735)
Acute kidney injury (684)
Drug-induced liver injury (684)
Off label use (640)
Condition aggravated (597)
Nausea (572)
Paradoxical drug reaction (570)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which RIFAMPIN Alternatives Have Lower Myelosuppression Risk?
RIFAMPIN vs RIFAMYCIN
RIFAMPIN vs RIFAPENTINE
RIFAMPIN vs RIFAXIMIN
RIFAMPIN vs RILMENIDINE
RIFAMPIN vs RILONACEPT